We are live on ! Find out more
SCA

Secor Capital Advisors Portfolio holdings

AUM $485M
1-Year Est. Return 3.33%
This Fund
S&P 500
This Quarter Est. Return
+6.41%
1 Year Est. Return
+3.33%
3 Year Est. Return
+43.51%
5 Year Est. Return
+39.33%
10 Year Est. Return
AUM
$1.17B
AUM Growth
-$49.2M
Cap. Flow
-$90.4M
Cap. Flow %
-7.74%
Top 10 Hldgs %
18%
Holding
718
New
222
Increased
121
Reduced
134
Closed
241

Top Sells

Rank Stock Value
1
VRSN icon
VeriSign
VRSN
+$9.22M
2
LRCX icon
Lam Research
LRCX
+$9.03M
3
AVY icon
Avery Dennison
AVY
+$9M
4
C icon
Citigroup
C
+$8.97M
5
SNPS icon
Synopsys
SNPS
+$8.86M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 12.91%
2 Industrials 12.07%
3 Technology 11.66%
4 Real Estate 8.29%
5 Financials 8.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DK icon
201
Delek US
DK
$3.87B
$1.83M 0.16%
+36,405
New +$1.81M
SAIA icon
202
Saia
SAIA
$11.3B
$1.82M 0.16%
+22,460
New +$1.73M
BAC icon
203
PUT
Bank of America
BAC
$435B
$1.81M 0.16%
64,200
-18,900
-23% -$564K
FBC
204
DELISTED
Flagstar Bancorp, Inc. New
FBC
$1.8M 0.15%
+52,654
New +$1.83M
RDUS
205
DELISTED
Radius Health, Inc.
RDUS
$1.77M 0.15%
+60,241
New +$1.9M
CMG icon
206
Chipotle Mexican Grill
CMG
$40.8B
$1.77M 0.15%
+205,600
New +$1.68M
GHDX
207
DELISTED
Genomic Health, Inc.
GHDX
$1.77M 0.15%
+35,202
New +$1.4M
MNR
208
DELISTED
Monmouth Real Estate Investment Corp
MNR
$1.77M 0.15%
107,338
+61,635
+135% +$954K
CMC icon
209
Commercial Metals
CMC
$7.63B
$1.77M 0.15%
+84,206
New +$1.88M
AKBA icon
210
Akebia Therapeutics
AKBA
$327M
$1.76M 0.15%
176,219
+106,470
+153% +$1.07M
LMNX
211
DELISTED
Luminex Corp
LMNX
$1.75M 0.15%
59,381
-25,834
-30% -$663K
CTRN icon
212
Citi Trends
CTRN
$524M
$1.75M 0.15%
63,861
-10,237
-14% -$308K
TVTX icon
213
Travere Therapeutics
TVTX
$5.33B
$1.74M 0.15%
+63,966
New +$1.7M
ABBV icon
214
PUT
AbbVie
ABBV
$458B
$1.74M 0.15%
19,000
+16,700
+726% +$1.63M
TCO
215
DELISTED
Taubman Centers Inc.
TCO
$1.74M 0.15%
+29,665
New +$1.67M
BOLD
216
DELISTED
Audentes Therapeutics, Inc
BOLD
$1.73M 0.15%
45,232
-15,564
-26% -$576K
ABBV icon
217
CALL
AbbVie
ABBV
$458B
$1.72M 0.15%
18,700
+16,500
+750% +$1.61M
SFLY
218
DELISTED
Shutterfly, Inc.
SFLY
$1.7M 0.15%
+18,910
New +$1.7M
EVRI
219
DELISTED
Everi Holdings
EVRI
$1.7M 0.15%
235,898
+115,638
+96% +$828K
XENT
220
DELISTED
Intersect ENT, Inc
XENT
$1.7M 0.15%
+45,335
New +$1.78M
CATO icon
221
Cato Corp
CATO
$65.9M
$1.7M 0.15%
68,935
+44,788
+185% +$883K
MEDP icon
222
Medpace
MEDP
$16.8B
$1.7M 0.15%
+39,430
New +$1.59M
INWK
223
DELISTED
InnerWorkings, Inc.
INWK
$1.69M 0.14%
194,585
+18,577
+11% +$171K
CRM icon
224
Salesforce
CRM
$134B
$1.67M 0.14%
12,249
-66,246
-84% -$8.45M
BOX icon
225
Box
BOX
$4.02B
$1.67M 0.14%
66,802
-126,512
-65% -$3.14M

Similar funds

Secor Capital Advisors's Q2 2018 Portfolio in Review

As of Q2 2018, Secor Capital Advisors held 718 positions worth $1.17B, down 4% from $1.22B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Secor Capital Advisors withdrew a net $90.4M in Q2 2018, closing 241 positions and reducing 134 holdings. Its most notable exit was VeriSign, an estimated $9.22M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 13% of assets, up from 11% a quarter earlier, followed by Industrials and Technology.

Against the trend, Secor Capital Advisors opened a new position in iShares MSCI Brazil ETF worth $7.35M.

  • Secor Capital Advisors's largest Q2 2018 buy was iShares MSCI Brazil ETF: 229,400 shares worth $7.35M.
  • Secor Capital Advisors added most to VanEck Russia ETF in Q2 2018, an estimated $12.4M increase.
  • Secor Capital Advisors's biggest Q2 2018 reduction was Salesforce, cutting an estimated $8.45M.
  • Secor Capital Advisors fully exited VeriSign in Q2 2018, selling an estimated $9.22M.
  • Secor Capital Advisors's ten largest holdings make up 18% of its $1.17B portfolio in Q2 2018.
  • Secor Capital Advisors opened 222 new positions and closed 241 in Q2 2018.
  • Secor Capital Advisors's portfolio value fell 4% quarter-over-quarter to $1.17B.

Based on Secor Capital Advisors's 13F filing for Q2 2018, filed 14 Aug 2018.